Delivery Order SPE2DE21D7010-SPE2D626F50X7

Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, was awarded a $2,438.82 fixed-price delivery order with economic price adjustment by the Defense Logistics Agency Medical Supply Chain on December 10, 2025, for ultimate completion by December 11, 2025. This delivery order, designated as contract M5, carries no set-aside restrictions and represents an open market procurement. The award funds the supply of specialized spinal surgery products and related medical technologies to be performed at Nuvasive's San Diego facility. As a critical supplier to the Department of Defense, Department of Veterans Affairs, and Defense Health Agency, Nuvasive delivers an extensive portfolio of spinal medical devices including fusion implants, interbody devices, bone graft materials, and surgical instruments that support advanced orthopedic and neurological surgical capabilities across federal healthcare systems.

This delivery order is likely issued under one of Nuvasive's existing indefinite delivery vehicle contracts, most notably the $8 million Blanket Purchase Agreement with the Defense Health Agency structured as an Indefinite Delivery/Indefinite Quantity contract vehicle effective through March 2027, or the Defense Logistics Agency Medical Supply Chain framework through which Nuvasive regularly receives task orders. The relatively modest order value and compressed timeline reflect the urgent medical supply demands of the military health system, where delivery orders typically span weeks to months for completion. Nuvasive's sustained contract activity with DLA Medical Supply Chain demonstrates its competitive standing among federal medical device suppliers and its critical role in maintaining advanced surgical capabilities across the Department of Defense and Veterans Health Administration networks.